NCIRS: Navigating vaccination for immunocompromised patients (webinar)

This month, the 国家免疫研究和监测中心 (NCIRS) will host webinar on vaccination in people with immunocompromise. 

Date: Wednesday 25 June
Time: 12:00–1:15 pm AEST 

For more information and to register, visit the webinar event page. 

MVEC recently held a webinar on immunisation and special risk groups which featured Prof Nigel Crawford and A/Prof Ben Teh; a recording of this event will soon be uploaded to our 教育门户, exclusively available to users with a paid membership. 


Vaccine administration error alert: Incorrect RSV prevention product

Inadvertent administration of adult RSV vaccines to infants

There have been a number of recent notifications of inadvertent administration of the adult RSV vaccine Abrysvo to infants in Victoria.

RSV vaccines, such as Abrsyvo and Arexvy, are not licensed for use in children. The safety and efficacy of these products in children has not been established. The only RSV prevention products recommended for eligible infants/young children are monoclonal antibody products, such as nirsevimab (Beyfortus). Current recommendations are for infants who have inadvertently received an RSV vaccine in error to be monitored for adverse events, and to receive a dose of nirsevimab.

Inadvertent administration of Arexvy in pregnancy

There have also been multiple notifications of inadvertent administration of Arexvy in pregnancy in Victoria.

Arexvy is not licensed for use in pregnancy, and there is limited data regarding its safety and efficacy in pregnancy. The only RSV vaccine recommended for use in pregnancy is Abrysvo, which is recommended between 28-36 weeks gestation. Current recommendations for women who have inadvertently received Arexvy in pregnancy do not recommend a follow up dose of Abrysvo within the same pregnancy. Nirsevimab may be considered for the infant.

Vaccine administration errors are preventable

Practices and immunisers should take appropriate steps to prevent errors, particularly in the context of a relatively new immunisation program. In the event of an error, the vaccinee or guardian should be informed via an open disclosure discussion. The error should also be reported to the jurisdiction’s vaccine safety service (SAEFVIC in Victoria).

All doses of RSV vaccines and nirsevimab should be reported to the 澳大利亚免疫登记 (AIR).

Further info


Register now: CVU mini on immunisation and special risk groups

MVEC’s upcoming webinar on immunisation and special risk groups is now open for registration. Healthcare professionals will have the opportunity to hear from Prof Nigel Crawford and A/Prof Benjamin Teh, followed by a brief Q&A session. 

日期: Wednesday 4 June 2025
时间: 6:00–7:00 pm AEST
地点: online
注册费用: free event (after the webinar, a recording will be exclusively available to Education Portal users with a paid membership) 

Register via MVEC’s 教育门户 now!

NB: You will need an Education Portal profile to register for this event, but you do not need a paid membership unless you would like to access the webinar recording. 


Immunisation Coalition: 2025 Pneumococcal Webinar

Immunisation Coalition will host its 2025 pneumococcal webinar on 25 June. Moderated by Dr Andrew Bird, the webinar will feature Angela Newbound. 

Date: 25 June 2025
Time: 6:00–7:00 pm (AEST) 

Learn more and register on the Immunisation Coalition event page. 


Immunisation Coalition webinar: MenB vaccination through general practice

Immunisation Coalition is holding a webinar on meningococcal disease, with a focus on menB vaccination, and participation in a GP practice clinical audit. Chaired by A/Prof Roy Rasalam, the session features Prof Robert Booy, Dr Leanne Jones and Ms Sonja Elia.

日期: 24 June 2025
时间: 6:30–7:30 pm (AEST) 

Learn more and register on the Immunisation Coalition event page. 


Benchmarque: eLearning modules on RSV protection for infants

Benchmarque Group has developed free modules on RSV protection for infants, aimed at providing participants with a baseline understanding of RSV information and an understanding of safe storage, preparation and administration of nirsevimab. 

The courses are available on the Benchmarque Group website.
Learn more about RSV at MVEC: RSV


ABC: Australia's childhood vaccination rates are declining, sparking fears about risk to herd immunity

ABC reports childhood vaccination rates have steadily declined since COVID-19. 

The article highlights decreases in vaccination rates overall among 2-year-old children and HPV vaccine uptake among teens. Experts and those with lived experience of vaccine-preventable disease emphasise the importance of herd protection and risks associated with disease. 

Read the ABC’s full article 了解更多信息。
NCIRS: Interim coverage data for 2024


Healthed: Current measles resurgence in Victoria, nationally and internationally (podcast)

MVEC director Prof Nigel Crawford recently appeared in a Healthed podcast episode to discuss the current measles situation in Australia and internationally.

The half-hour episode covers:

  • clinical features and diagnosis of measles 
  • managing measles in general practice 
  • vaccination guidelines 
  • public health considerations 
  • use of immunoglobulin for immunosuppressed patients. 

Listen now via Healthed’s website (CPD available).
Learn more about measles at MVEC:麻疹


Healthed: Measles cases are rising rapidly – and young travellers are at particular risk

In a recent article for Healthed, MVEC director Prof Nigel Crawford examines the recent resurgence of measles cases in Victoria. 

Prof Crawford addresses special considerations for infants travelling overseas, and more. 

Read the article in full via Healthed’s website (CPD available).
Learn more about measles at MVEC:麻疹


Victorian Department of Health: Measles alerts continue

Victorian Department of Health’s alert on measles continues to be updated. The latest update on 19 May 2025 includes an up-to-date list of active exposure sites in Victoria.

According to the Health Department, a significant number of recent measles cases have acquired their infection locally in Victoria. The majority of recent cases have arisen in people who have not had two documented doses of the MMR vaccine.

Read the alert in full at the department’s page Health alerts: New measles case in Victoria.

Learn more about measles disease and vaccination at MVEC:麻疹
Check out MVEC director Prof Nigel Crawford’s recent Healthed article

podcast which both cover the current measles resurgence. 


关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。